PDCD1 and cancer: Enhanced inhibitory signalling is associated with NK cells receiving inhibitory signals from cancer cells that retain HLA expression and/or overexpression of inhibitory receptors such as PD-1, PD-L1, NKG2A, and T-cell immunoglobulin and ITIM domain (TIGIT).